Seawater drowning-associated pneumonia: a 10-year descriptive cohort in intensive care unit

Alexandre Robert1, Pierre-Éric Danin2,3, Hervé Quintard4,5

  • 1Service de Réanimation Médicale, Hôpital l'Archet 1, CHU de Nice, 151 Route Saint Antoine de Ginestière, CS 23079, 06202, Nice Cedex 3, France. robert.a@chu-nice.fr.

Abstract

Insights

Seawater drowning pneumonia typically involves common bacteria with low resistance. Early respiratory samples are crucial for appropriate antibiotic selection, guiding treatment for Gram-negative bacteria in severe cases.

Area of Science:

  • Marine toxicology
  • Infectious disease epidemiology
  • Critical care medicine

Background:

  • Pneumonia is a significant complication of drowning.
  • Optimal empirical antibiotic treatment for drowning-associated pneumonia remains undefined.
  • Limited data exists on microbial profiles in seawater drowning pneumonia compared to freshwater.

Purpose of the Study:

  • To identify microorganisms in early respiratory samples from seawater drowning pneumonia patients.
  • To determine the antibiotic susceptibility patterns of these identified microorganisms.

Main Methods:

  • Retrospective analysis of patients admitted for seawater drowning between 2003-2013.
  • Inclusion of patients from intensive care units in a high drowning rate region of France.
  • Analysis of demographic, antimicrobial therapy, and microbiological data from respiratory samples collected within 48 hours of admission.

Main Results:

  • Of 74 patients, 36 (49%) had pneumonia; overall mortality was 26%.
  • Sixteen of 24 respiratory samples (67%) collected within 48 hours were positive.
  • Predominant microorganisms included Enterobacteriaceae and Gram-positive cocci with low resistance; no multidrug-resistant bacteria or fungi were found.

Conclusions:

  • Microorganisms in seawater drowning pneumonia are often oro-pharyngeal flora or Enterobacteriaceae with low antimicrobial resistance.
  • Collecting respiratory samples upon ICU admission is vital to prevent inappropriate treatment.
  • Empirical cephalosporin use may be reserved for severe cases or confirmed Gram-negative bacilli.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.1K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.8K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.0K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
963
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
3.6K
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1.0K